| Literature DB >> 31696705 |
Jingyang Shan1, Xiao Li1, Kaili Yang1, Weijun Xiu1, Qirui Wen1, Yuqian Zhang1, Lihui Yuwen1, Lixing Weng2, Zhaogang Teng3, Lianhui Wang1.
Abstract
Antibacterial agents with high antibacterial efficiency and bacteria-binding capability are highly desirable. Herein, we describe the successful preparation of Cu2WS4 nanocrystals (CWS NCs) with excellent antibacterial activity. CWS NCs with small size (∼20 nm) achieve more than 5 log (>99.999%) inactivation efficiency of both Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative) at low concentration (<2 μg mL-1) with or without ambient light, which is much better than most of the reported antibacterial nanomaterials (including Ag, TiO2, etc.) and even better than the widely used antibiotics (vancomycin and daptomycin). Antibacterial mechanism study showed that CWS NCs have both enzyme-like (oxidase and peroxidase) properties and selective bacteria-binding ability, which greatly facilitate the production of reactive oxygen species to kill bacteria. Animal experiments further indicated that CWS NCs can effectively treat wounds infected with methicillin-resistant Staphylococcus aureus (MRSA). This work demonstrates that CWS NCs have the potential as effective antibacterial nanozymes for the treatment of bacterial infection.Entities:
Keywords: Cu2WS4 nanocrystals; antibacterial activity; bacteria binding; nanozyme; reactive oxygen species
Year: 2019 PMID: 31696705 DOI: 10.1021/acsnano.9b03868
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881